Related Experiment Video
Updated: Sep 27, 2026

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
Published on: March 5, 2020
Subacute stent thrombosis associated with a heparin-coated stent and heparin-induced thrombocytopenia
Daniel Cruz1, Ronald Karlsberg, Yuzuru Takano
1Department of Cardiology, University of California, Los Angeles, California, USA.
Subacute stent thrombosis occurred in a patient 34 days after receiving a heparin-coated (HC) stent. The patient developed heparin-induced thrombocytopenia and diffuse thrombosis after the stent was placed. This raises the concern that patients who develop heparin-associated antibodies in the context of a recently placed HC stent may have an increased risk for subacute stent thrombosis.
Subacute stent thrombosis occurred in a patient 34 days after receiving a heparin-coated (HC) stent. The patient developed heparin-induced thrombocytopenia and diffuse thrombosis after the stent was placed. This raises the concern that patients who develop heparin-associated antibodies in the context of a recently placed HC stent may have an increased risk for subacute stent thrombosis.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Transient Ischemic Attack l: Introduction
Cardiac Catheterization I: Pre-Procedure Overview
